Loading...
Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma
PURPOSE: Adrenocortical carcinoma (ACC) is a rare tumor with very poor prognosis and no effective treatment. The aim of this study was to explore a novel therapy co-targeting EGFR and IGF1R in vitro and vivo. METHODS: The expression of EGFR and IGF1R were evaluated in a series of adrenocortical tumo...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5094996/ https://ncbi.nlm.nih.gov/pubmed/27105537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8827 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|